BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, August 2, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for Feb. 6, 2020

Feb. 6, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bgi, Bioventrix, Curetis, Fibroline, Gatt Technologies, MGI Tech, Nano-X Imaging, Quaphaco, Smith & Nephew, USArad Holdings.
Read More

Financings for Feb. 6, 2020

Feb. 6, 2020
Med-tech firms raising money in public or private financings, including: Connectyx Technologies, Lunaphore Technologies, Pentixapharm, Rewalk Robotics.
Read More

Appointments and advancements for Feb. 6, 2020

Feb. 6, 2020
New hires and promotions in the med-tech industry, including: Angiodynamics, Apertiva, Procept Biorobotics, Sonendo, Syntactx.
Read More

Regulatory actions for Feb. 6, 2020

Feb. 6, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aquestive, Blueprint, Chiesi, Kleo, Neurosense, Novan, Protalix, Realta, Revance.
Read More

Other news to note for Feb. 6, 2020

Feb. 6, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atreca, Aurigene, Chiesi, Curis, Evgen, Foamix, Generex, Genprex, Janone, Jounce, Marinomed, Menlo Therapeutics, Merck, Nanostring, Oncternal, Scholar Rock, Summit.
Read More

In the clinic for Feb. 6, 2020

Feb. 6, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arrowhead, Cytodyn, Cytokinetics, Faron, Foamix, Lineage Cell, Novan, PTC, Roche, Sanofi, Scholar Rock, Tonix.
Read More

Financings for Feb. 6, 2020

Feb. 6, 2020
Biopharmas raising money in public or private financings, including: AGTC, Arch Biopartners, Atyr, Beam, Chi-Med, Cortexyme, Kineticos, Moleculin, Pentixapharm, Sonoma, Valo.
Read More

Earnings for Feb. 6, 2020

Feb. 6, 2020
Quarterly snapshots from biopharma companies with marketed products, including: Alnylam, Regeneron.
Read More

Appointments and advancements for Feb. 5, 2020

Feb. 5, 2020
New hires and promotions in the med-tech industry, including: Cellavision, Conformis, Imagion Biosystems, Leadingreach.
Read More

Financings for Feb. 5, 2020

Feb. 5, 2020
Med-tech firms raising money in public or private financings, including: Integra Lifesciences Holdings, Itamar Medical, Jenavalve Technology, Verana Health.
Read More
Previous 1 2 … 1727 1728 1729 1730 1731 1732 1733 1734 1735 … 1830 1831 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 31, 2026.
  • HIV virus

    AIDS 2026: New targets for metabolic dysfunction despite ART

    BioWorld
    Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
  • Jingxin discloses new muscarinic and sigma receptor agonists

    BioWorld Science
    Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
  • Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

    BioWorld Science
    Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
  • Silhouette illustration of DNA gene editing

    Death in Chinese gene-editing trial exposes ethical fault lines

    BioWorld
    The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing